|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.36 USD | +0.30% |
|
-6.41% | -43.24% |
| 04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
| 01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
Mural Oncology plc(NasdaqGM:MURA) dropped from S&P Biotechnology Select Industry Index
| 1st Jan change | Capi. | |
|---|---|---|
| -43.24% | 56.86M | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
MURAL ONCOLOGY PLC 
